Company Description
Depressed because you can't smoke anymore? Targacept might be able to help as it researches how to put the nervous system's nicotinic receptors to...
Key Targacept Financials
| Company Type | Public - NASDAQ (GM): TRGT Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $11.6 |
| 2006 Employees | 89 |
More Targacept Financials (8 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Targacept's competition across multiple industries
Top Targacept Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Targacept Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Mark B. Skaletsky | Network | E-mail |
| President, CEO, and Director | J. Donald (Don) deBethizy | Network | E-mail |
| VP, CFO, Treasurer, and Secretary | Alan A. Musso | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Targacept News
- Targacept, Inc. (TRGT) Corporate Event Announcement Notice [Wall Street Horizon] (04 Jul 2008 21:00:00 EDT)
- Targacept, Inc. (TRGT) Corporate Event Announcement Notice [Wall Street Horizon] (03 Jul 2008 21:15:00 EDT)
- EDITORIAL: Targacept's New Challenge [Winston-Salem Journal (NC)] (19 Jun 2008 04:00:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.